Alector raises $133M series E

Immuno-neurology and immuno-oncology company Alector Inc. (South San Francisco, Calif.) raised $133 million in a series E round.

Participants included new investors Deerfield Management, Federated Kaufmann Fund, Section 32, Euclidean Capital, Foresite Capital, Lilly Asia Ventures, New Leaf Venture Partners, Perceptive Advisors and Casdin Capital. Also participating were existing investors AbbVie Ventures, Polaris Partners, OrbiMed, MRL Ventures, GV, the Dementia Discovery Fund, Mission Bay Capital, Amgen Ventures and other undisclosed investors...